Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
5.86
Nov 03 • 10:28 AM ET Dollar change+0.01 Percentage change(0.26%)
Index
-
Market Cap
50.45M
Enterprise Value
61.78M
Income
14.31M
Sales
43.90M
Book/sh
0.32
Cash/sh
1.09
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
55
IPO
Sep 30, 2009
P/E
24.39
Forward P/E
-
PEG
-
P/S
1.15
P/B
18.10
P/C
5.38
P/FCF
11.98
EV/EBITDA
30.14
EV/Sales
1.41
Quick Ratio
0.89
Current Ratio
1.28
Debt/Eq
7.42
LT Debt/Eq
5.41
Option/Short
No / Yes
EPS (ttm)
0.24
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
38.05% 61.12%
EPS Y/Y TTM
119.59%
Sales Y/Y TTM
12.02%
EPS Q/Q
-1216.90%
Sales Q/Q
-4.18%
Insider Own
5.42%
Insider Trans
-7.09%
Inst Own
47.87%
Inst Trans
-15.19%
ROA
41.10%
ROE
-
ROIC
80.01%
Gross Margin
73.96%
Oper. Margin
1.54%
Profit Margin
32.60%
SMA20
9.33%
SMA50
20.48%
SMA200
-55.83%
Trades
Shs Outstand
8.60M
Shs Float
8.14M
52W High
36.20 -83.80%
52W Low
3.92 49.62%
Volatility
7.09% 6.98%
ATR (14)
0.37
RSI (14)
63.07
Beta
1.46
Rel Volume
1.83
Avg Volume
61.19K
Volume
21,386
Perf Week
14.33%
Perf Month
24.79%
Perf Quarter
-1.76%
Perf Half Y
-62.50%
Perf YTD
-80.35%
Perf Year
-78.61%
Perf 3Y
4.27%
Perf 5Y
-86.97%
Perf 10Y
-91.31%
Prev Close
5.85
Price
5.86
Change %
0.26%
Consensus
Strong Buy
Avg. Price Target
$40.00
Implied Upside
+582.0%
Analysts2incl. previous ratings
Rating Distribution2 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 03, 2025Initiated
NNorthland Capital
Outperform$55+837.8%
Jul 29, 2025Initiated
RRoth Capital
Buy$49+735.5%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Opaleye Management Inc.10% OwnerApr 30 '26Sale16.1525,000403,7755,500May 04 04:05 PM
Opaleye Management Inc.10% OwnerMay 01 '26Sale16.1110,581170,4655,000May 04 04:05 PM
Opaleye Management Inc.10% OwnerApr 28 '26Sale18.4746,288854,8197,500Apr 30 04:10 PM
Opaleye Management Inc.10% OwnerApr 29 '26Sale17.2524,360420,1526,500Apr 30 04:10 PM
Opaleye Management Inc.10% OwnerApr 17 '26Sale20.4616,267332,84110,000Apr 21 06:17 PM
Opaleye Management Inc.10% OwnerApr 21 '26Sale20.502024,142954,798Apr 21 06:17 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 11 '25Sale31.2813,500422,27770,499Dec 15 05:22 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 12 '25Sale21.046,500136,78963,999Dec 15 05:22 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 08 '25Sale30.75125,4003,856,050881,390Dec 10 09:21 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 09 '25Sale30.588,785268,679872,605Dec 10 09:21 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 10 '25Sale30.398,625262,129863,980Dec 10 09:21 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 08 '25Sale31.602,00063,2032,000Dec 10 09:21 PM
SANUWAVE Health, Inc. is a medical device company providing directed energy products into the wound care space. It engages in the development and marketing of directed energy products that utilize ultrasound technology. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
CEO & ChairmanMr. Morgan C. Frank
Chief Operating OfficerMr. Daniel Coyle
Executive Vice President of SalesMr. Timothy Wern
CFO & SecretaryMr. Peter Sorensen
Chief Technology OfficerDr. Christopher Cook Ph.D.